Highlights from Q1 2022 Webinar
It was great to see over 100 drug hunters at our first drug discovery webinar! You can find the video and slides at the bottom of this page. The scope of this talk grew to be a bit massive as we were planning it, so we decided to split it into two parts. This first…
“It Always Seems Impossible Until It’s Done”
with Dr. Romyr Dominique Contrary to popular belief, pharma is incredibly competitive, with dozens of companies often working on the same hot target at the same time. What sets pharma apart from the outside world though, is how deeply we respect our competitors and other scientists when they succeed at cracking technical challenges. Here, Dr.…
It Takes a Village
with Joachim Rudolph New drugs are discovered by teams, not individuals. “Drug discovery is a complex undertaking, and I enjoy the collaboration with many people from different disciplines and expertise areas that it takes to solve this impossible puzzle,” says reviewer Joachim Rudolph. Drug Hunter also takes a community to build, and we want to celebrate…
“Don’t Work on Things That Don’t Work”
At the time of this writing Kim Huard was one of Genentech’s Senior Scientists, and has spent a decade looking for new medicines. She spent eight years at Pfizer at the Groton and Cambridge sites before joining us in California. She’s currently a Director in the Discovery Chemistry department leading teams of scientists in pursuit…
The Post-Gleevec Era
Gleevec (imatinib) was the first tyrosine kinase inhibitor approved for the treatment of cancer and one of the first products to emerge from “rational drug design.” It’s invention changed chronic myeloid leukemia from an incurable death sentence to a manageable disease. Here’s a look back on the tremendous value it’s created over the last two…